合成路线1
该中间体在本合成路线中的序号:
(I) 3-Chloro-4-fluoroaniline (I), condensed by heating at 125 C with diethyl ethoxymethylenemalonate (A), gives diethyl 3-chloro-4-fluoroanilinomethylenemalonate (II). The thermal cyclization of (II) by reflux in A Dowtherm gives ethyl 6-fluoro-7-chloro-4-hydroxyquinoline-3-carboxylate (III), which, alkylated by ethyliodide in DMF with potassium carbonate, leads to ethyl 1-ethyl-6 fluoro-7-chloro-4-oxo-1,4-dihydroquinoline-3-carboxylate (IV), purified by recrystallization. The ester (IV), after saponification and acidification, provides the corresponding acid (V). 1-Ethyl-6-fluoro-7-chloro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (V), heated to 100 C in pyridine with 1-methylpiperazine (B), leads to 1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (VI). The salification of (VI) with methanesulfonic acid provides the salt.
【1】
Pesson, M.; Montay, G.; Goueffon, Y.; Roquet, F.; Microbiologie: Sur un nouvel antibacterien de synthese:l¡Acide ethyl-2-fluoro-6-(methyl-4-piperazinyl-1)-oxo-4-dihydro-1,4-quinoleine-3-carboxylique (1589 RB). CR Acad Sci Paris 1981, 292.
|
【2】
Bellon, A.; Pefloxacin mesylate. Drugs Fut 1982, 7, 9, 646.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(A) |
14088 |
Diethyl ethoxymethylenemalonate; Diethyl 2-(ethoxymethylene)malonate
|
87-13-8 |
C10H16O5 |
详情 | 详情
|
(I) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
(II) |
32073 |
Diethyl 2-[[(3-chloro-4-fluorophenyl)imino]methyl]malonate; Diethyl 3-chloro-4-fluoroanilinomethylenemalonate
|
|
C14H15ClFNO4 |
详情 |
详情
|
(III) |
32074 |
Ethyl 7-chloro-6-fluoro-4-hydroxy-1,4-dihydro-3-quinolinecarboxylate
|
|
C12H11ClFNO3 |
详情 |
详情
|
(IV) |
32075 |
ethyl 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C14H13ClFNO3 |
详情 |
详情
|
(V) |
32076 |
7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
68077-26-9 |
C12H9ClFNO3 |
详情 | 详情
|
(VI) |
32077 |
1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C17H20FN3O3 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(V) Monodemethylation of 6,7-dimethoxyquinazolin-4(3H)-one (I) in refluxing methanesulfonic acid in the presence of L-methionine provides 6-hydroxy-7-methoxyquinazolin-4(3H)-one (II), which is acetylated with acetic anhydride and pyridine at 100 C to give the acetate (III). Treatment of compound (III) with refluxing SOCl2 and a catalytic amount of DMF yields chloride (IV), which by condensation with 3-chloro-4-fluoroaniline (V) in boiling isopropanol affords the anilinoquinazoline (VI). Hydrolysis of the acetate group of (VI) by treatment with NH4OH in refluxing MeOH gives the 6-hydroxyquinazoline derivative (VII), which finally is alkylated with 3-(4-morpholinyl)-propyl chloride (VIII) or 3-(4-morpholinyl)propyl bromide (IX).
【1】
Gibson, K.H.; Grundy, W.; Barker, A.J.; et al.; Studies leading to the identification of ZD1839 (Iressa(TM)): An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg Med Chem Lett 2001, 11, 14, 1911. |
【2】
D'Souza, N.; Castañer, J.; Levin, M.; Iressa. Drugs Fut 2002, 27, 4, 339.
|
【3】
Gibson, K.H. (AstraZeneca plc); Quinazoline derivs.. EP 0823900; JP 1999504033; US 5770599; WO 9633980 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18684 |
6,7-dimethoxy-4(3H)-quinazolinone
|
13794-72-4 |
C10H10N2O3 |
详情 | 详情
|
(II) |
18685 |
6-hydroxy-7-methoxy-4(3H)-quinazolinone
|
179688-52-9 |
C9H8N2O3 |
详情 | 详情
|
(III) |
18686 |
7-methoxy-4-oxo-3,4-dihydro-6-quinazolinyl acetate
|
179688-53-0 |
C11H10N2O4 |
详情 | 详情
|
(IV) |
18687 |
4-chloro-7-methoxy-6-quinazolinyl acetate
|
230955-75-6 |
C11H9ClN2O3 |
详情 | 详情
|
(V) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
(VI) |
18689 |
4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinyl acetate
|
788136-89-0 |
C17H13ClFN3O3 |
详情 | 详情
|
(VII) |
18690 |
4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinol
|
184475-71-6 |
C15H11ClFN3O2 |
详情 | 详情
|
(VIII) |
18691 |
4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine |
7357-67-7 |
C7H14ClNO |
详情 | 详情
|
(IX) |
52653 |
4-(3-bromopropyl)morpholine
|
125422-83-5 |
C7H14BrNO |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) 4-Chloro-7-fluoro-6-nitroquinazoline (I) was condensed with 3-chloro-4-fluoroaniline (II) to afford the 4-anilino quinazoline (III). Displacement of the activated fluorine of (III) with the potassium alkoxide of morpholinopropanol (IV) gave the morpholinopropyl ether (V). Subsequent reduction of the nitro group of (V), either using iron dust and acetic acid or catalytic hydrogenation over Raney-Ni, furnished aminoquinazoline (VI). This was finally condensed with acrylic acid (VII), via activation as the mixed anhydride with isobutyl chloroformate or using EDC as the coupling reagent, to provide the title acrylamide.
【1】
Loo, J.A.; Rewcastle, G.W.; Smaill, J.B.; et al.; Tyrosine kinase inhibitors.17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(Phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides baring additional solubilizing functions. J Med Chem 2000, 43, 7, 1380. |
【2】
Bridges, A.J.; Klohs, W.D.; Driscoll, D. (Pfizer Inc.); N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases. EP 1131304; US 6344455; WO 0031048 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19142 |
4-chloro-7-fluoro-6-nitroquinazoline
|
|
C8H3ClFN3O2 |
详情 |
详情
|
(II) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
(III) |
54956 |
N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine; N-(3-chloro-4-fluorophenyl)-N-(7-fluoro-6-nitro-4-quinazolinyl)amine
|
162012-67-1 |
C14H7ClF2N4O2 |
详情 | 详情
|
(IV) |
54957 |
3-(4-morpholinyl)-1-propanol
|
|
C7H15NO2 |
详情 |
详情
|
(V) |
54958 |
N-(3-chloro-4-fluorophenyl)-7-[3-(4-morpholinyl)propoxy]-6-nitro-4-quinazolinamine; N-(3-chloro-4-fluorophenyl)-N-{7-[3-(4-morpholinyl)propoxy]-6-nitro-4-quinazolinyl}amine
|
|
C21H21ClFN5O4 |
详情 |
详情
|
(VI) |
54959 |
N-{6-amino-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl}-N-(3-chloro-4-fluorophenyl)amine; N~4~-(3-chloro-4-fluorophenyl)-7-[3-(4-morpholinyl)propoxy]-4,6-quinazolinediamine
|
|
C21H23ClFN5O2 |
详情 |
详情
|
(VII) |
19139 |
acrylic acid
|
79-10-7 |
C3H4O2 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(V) The reaction of 5-bromo-2-(methylsulfanyl)pyrimidine-4-carboxylic acid (I) with ammonia and CuSO4 in water gives 5-amino-2-(methylsulfanyl)pyrimidine-4-carboxylic acid (II), which is cyclized with formamide or formamidine acetate by heating at 180 C to yield 4-hydroxy-6-(methylsulfanyl)pyrimido[5,4-d]pyrimidine (III). The reaction of (III) with refluxing SOCl2 affords the corresponding 4-chloro derivative (IV), which is condensed with 3-chloro-4-fluoroaniline (V) in hot dioxane to provide the secondary amine (VI). Alternatively, (VI) can also be obtained by direct condensation of the 4-hydroxy compound (III) with aniline (V) by means of HMDS and Ts-OH at 140 ?C. The oxidation of the sulfanyl group of (VI) with MCPBA in dichloromethane provides a mixture of the sulfinyl derivative (VII) and the sulfonyl derivative (VIII), which, without isolation, is finally condensed with 1-methylpiperidin-4-amine (IX) by means of DIEA in hot DMF to give the target pyrimido-pyrimidine-diamine.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
54678 |
5-bromo-2-(methylsulfanyl)-4-pyrimidinecarboxylic acid
|
|
C6H5BrN2O2S |
详情 |
详情
|
(II) |
54679 |
5-amino-2-(methylsulfanyl)-4-pyrimidinecarboxylic acid
|
|
C6H7N3O2S |
详情 |
详情
|
(III) |
54680 |
6-(methylsulfanyl)pyrimido[5,4-d]pyrimidin-4-ol
|
|
C7H6N4OS |
详情 |
详情
|
(IV) |
54681 |
8-chloro-2-(methylsulfanyl)pyrimido[5,4-d]pyrimidine; 8-chloropyrimido[5,4-d]pyrimidin-2-yl methyl sulfide
|
|
C7H5ClN4S |
详情 |
详情
|
(V) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
(VI) |
54682 |
N-(3-chloro-4-fluorophenyl)-6-(methylsulfanyl)pyrimido[5,4-d]pyrimidin-4-amine; N-(3-chloro-4-fluorophenyl)-N-[6-(methylsulfanyl)pyrimido[5,4-d]pyrimidin-4-yl]amine
|
|
C13H9ClFN5S |
详情 |
详情
|
(VII) |
54683 |
N-(3-chloro-4-fluorophenyl)-6-(methylsulfinyl)pyrimido[5,4-d]pyrimidin-4-amine; N-(3-chloro-4-fluorophenyl)-N-[6-(methylsulfinyl)pyrimido[5,4-d]pyrimidin-4-yl]amine
|
|
C13H9ClFN5OS |
详情 |
详情
|
(VIII) |
54684 |
N-(3-chloro-4-fluorophenyl)-6-(methylsulfonyl)pyrimido[5,4-d]pyrimidin-4-amine; N-(3-chloro-4-fluorophenyl)-N-[6-(methylsulfonyl)pyrimido[5,4-d]pyrimidin-4-yl]amine
|
|
C13H9ClFN5O2S |
详情 |
详情
|
(IX) |
54685 |
1-methyl-4-piperidinamine; 1-methyl-4-piperidinylamine
|
|
C6H14N2 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(VI) The condensation of 3-ethoxy-4-nitroaniline (I) with 2-(ethoxymethylene)cyanacetic acid ethyl ester (II) in refluxing toluene gives the adduct (III), which is further cyclized in Dowtherm at 258 C to yield 7-ethoxy-6-nitro-4-oxo-1,4-dihydroquinoline-3-carbonitrile (IV). The reaction of (IV) with refluxing POCl3 affords the 4-chloroquinoline (V), which is condensed with 3-chloro-4-fluoroaniline (VI) in refluxing isopropanol to provide the secondary amine (VII). The reduction of the nitro group of (VII) with Fe and NH4Cl in refluxing methanol/water gives the corresponding amino derivative (VIII), which is condensed with the acid chloride (IX) by means of t-BuOCOCl and NMM in THF to yield the amide (X). Finally, this compound is treated with dimethylamine in THF to afford the target quinoline-3-carbonitrile.
【1】
Wissner, A.; Overbeek, E.; Reich, M.F.; Floyd, B.; Johnson, B.D.; Mamuya, N.; Rosfjord, E.C.; Discafani, C.; Davis, R.; Shi, X.; Rabindran, S.K.; Gruber, B.C.; Ye, F.; Hallett, W.A.; Nilakantan, R.; Shen, R.; Wang, Y.-F.; Greenberger, L.M.; Tsou, H.-R.; Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epi. J Med Chem 2003, 46, 1, 49. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
61513 |
3-ethoxy-4-nitroaniline; 3-ethoxy-4-nitrophenylamine
|
|
C8H10N2O3 |
详情 |
详情
|
(II) |
61514 |
ethyl (Z)-2-cyano-3-propoxy-2-propenoate
|
|
C9H13NO3 |
详情 |
详情
|
(III) |
61515 |
ethyl (E)-2-cyano-3-(3-ethoxy-4-nitroanilino)-2-propenoate
|
|
C14H15N3O5 |
详情 |
详情
|
(IV) |
61516 |
7-ethoxy-6-nitro-4-oxo-1,4-dihydro-3-quinolinecarbonitrile
|
|
C12H9N3O4 |
详情 |
详情
|
(V) |
61517 |
4-chloro-7-ethoxy-6-nitro-3-quinolinecarbonitrile
|
|
C12H8ClN3O3 |
详情 |
详情
|
(VI) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
(VII) |
61518 |
4-(3-chloro-4-fluoroanilino)-7-ethoxy-6-nitro-3-quinolinecarbonitrile
|
|
C18H12ClFN4O3 |
详情 |
详情
|
(VIII) |
61519 |
6-amino-4-(3-chloro-4-fluoroanilino)-7-ethoxy-3-quinolinecarbonitrile
|
|
C18H14ClFN4O |
详情 |
详情
|
(IX) |
50564 |
(E)-4-bromo-2-butenoyl chloride
|
|
C4H4BrClO |
详情 |
详情
|
(X) |
61520 |
(E)-4-bromo-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-2-butenamide
|
|
C22H17BrClFN4O2 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(V) Condensation of cyano ester (I) with formamidine in the presence of NaOEt afforded the pyrimidinone derivative (II). Acetal hydrolysis of (II) with concomitant intramolecular cyclization under acidic conditions produced the pyrrolopyrimidinone (III), which was further chlorinated to (IV) in refluxing POCl3. Displacement of the 4-chloro of (IV) with 3-chloro-4-fluoroaniline (V) in the presence of silver triflate in hot DMF afforded the anilino pyrrolopyrimidine (VI). Oxidation of (VI) using pyridinium bromide perbromide furnished the alpha,alpha-dibromo lactam (VII). Reductive debromination of (VII) by means of zinc dust in AcOH gave intermediate (VIII).
【1】
Wei, C.C.; Tang, P.C.; McMahon, G.; Sun, L.; Hirth, K.P.; Liang, C.; Cui, J. (Sugen, Inc.); 4-Substd. 7-aza-indolin-2-ones and their use as protein kinase inhibitors. EP 1244672; WO 0146196 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14789 |
ethyl 2-cyano-4,4-diethoxybutanoate
|
|
C11H19NO4 |
详情 |
详情
|
(II) |
60644 |
2-[4-bromo-2-(2-fluorobenzoyl)anilino]-2-oxoethyl 4-methylbenzenesulfonate
|
|
C22H17BrFNO5S |
详情 |
详情
|
(III) |
60045 |
3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one
|
|
C6H5N3O |
详情 |
详情
|
(IV) |
60046 |
4-chloro-7H-pyrrolo[2,3-d]pyrimidine;6-Chloro-7-deazapurine;4-chloropyrrolo[2,3-d]pyrimidine;4-Chloro-1H-pyrrolo[2,3-d]pyrimidine |
3680-69-1 |
C6H4ClN3 |
详情 | 详情
|
(V) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
(VI) |
60850 |
N-(3-chloro-4-fluorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine; N-(3-chloro-4-fluorophenyl)-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amine
|
|
C12H8ClFN4 |
详情 |
详情
|
(VII) |
60851 |
5,5-dibromo-4-(3-chloro-4-fluoroanilino)-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one
|
|
C12H6Br2ClFN4O |
详情 |
详情
|
(VIII) |
60852 |
4-(3-chloro-4-fluoroanilino)-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one
|
|
C12H8ClFN4O |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(XIV) Vilsmeier formylation of ethyl 4-methylpyrrole-2-carboxylate (VIII) affords aldehyde (IX). The ethyl ester group of (IX) is subsequently hydrolyzed under alkaline conditions to provide acid (X). Coupling of (X) with 4-(2-aminoethyl)morpholine (XI) gives amide (XII). Then, condensation between aldehyde (XII) and lactam (VII) in the presence of piperidine leads to adduct (XIII). The 4-chloro group of (XIII) is finally displaced with 3-chloro-4-fluoroaniline (XIV) in hot NMP to provide the title compound
【1】
Wei, C.C.; Tang, P.C.; McMahon, G.; Sun, L.; Hirth, K.P.; Liang, C.; Cui, J. (Sugen, Inc.); 4-Substd. 7-aza-indolin-2-ones and their use as protein kinase inhibitors. EP 1244672; WO 0146196 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VII) |
60048 |
4-chloro-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one
|
|
C6H4ClN3O |
详情 |
详情
|
(VIII) |
60049 |
ethyl 4-methyl-1H-pyrrole-2-carboxylate
|
|
C8H11NO2 |
详情 |
详情
|
(IX) |
60050 |
ethyl 5-formyl-4-methyl-1H-pyrrole-2-carboxylate
|
|
C9H11NO3 |
详情 |
详情
|
(X) |
60051 |
5-formyl-4-methyl-1H-pyrrole-2-carboxylic acid
|
|
C7H7NO3 |
详情 |
详情
|
(XI) |
12880 |
4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide
|
2038-03-1 |
C6H14N2O |
详情 | 详情
|
(XII) |
59999 |
5-formyl-4-methyl-N-[2-(4-morpholinyl)ethyl]-1H-pyrrole-2-carboxamide
|
|
C13H19N3O3 |
详情 |
详情
|
(XIII) |
59998 |
5-[(4-chloro-6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-5-ylidene)methyl]-4-methyl-N-[2-(4-morpholinyl)ethyl]-1H-pyrrole-2-carboxamide
|
|
C19H21ClN6O3 |
详情 |
详情
|
(XIV) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(VIII)
【1】
Welham MJ.2005.Process for the manufacture。gefitinib. W0 2005023783(本专利为AstraZeneca plc所有) |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
66436 |
(E)-N,N'-bis(3-chloro-4-fluorophenyl)formimidamide |
|
C13H8Cl2F2N2 |
详情 | 详情
|
(VIII) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(X)
【1】
Jyothi Prasad R. 2005. An improved process for the preparation of gefitinib. WO2005023783(本专利为Natco Pharma Ltd所有) |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18455 |
3-hydroxy-4-methoxybenzaldehyde; Isovanillin
|
621-59-0 |
C8H8O3 |
详情 | 详情
|
(II) |
66437 |
4-methoxy-3-(3-morpholinopropoxy)benzaldehyde |
861453-11-4 |
C15H21NO4 |
详情 | 详情
|
(III) |
66438 |
4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzaldehyde |
|
C15H20N2O6 |
详情 | 详情
|
(IV) |
66439 |
(Z)-4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzaldehyde oxime |
|
C15H21N3O6 |
详情 | 详情
|
(V) |
66434 |
4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile |
675126-26-8 |
C15H19N3O5 |
详情 | 详情
|
(VI) |
66440 |
4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzamide |
|
C15H21N3O6 |
详情 | 详情
|
(VII) |
66441 |
2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide |
|
C15H23N3O4 |
详情 | 详情
|
(VIII) |
66442 |
7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one |
|
C16H21N3O4 |
详情 | 详情
|
(IX) |
66443 |
4-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine |
|
C16H20ClN3O3 |
详情 | 详情
|
(X) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(VIII)
【1】
Chandregowda V,Rao GV, Reddy GC. 2007. One-pot conversion of 2-nitrobenzonitriles to quinazolin-4(3H)-ones and synthesis of gefitinib and erlotinib hydrochloride. Heterocycles,71(1): 39~48 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18455 |
3-hydroxy-4-methoxybenzaldehyde; Isovanillin
|
621-59-0 |
C8H8O3 |
详情 | 详情
|
(II) |
18691 |
4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine |
7357-67-7 |
C7H14ClNO |
详情 | 详情
|
(III) |
66437 |
4-methoxy-3-(3-morpholinopropoxy)benzaldehyde |
861453-11-4 |
C15H21NO4 |
详情 | 详情
|
(IV) |
66444 |
(Z)-4-methoxy-3-(3-morpholinopropoxy)benzaldehyde oxime |
|
C15H22N2O4 |
详情 | 详情
|
(V) |
66433 |
4-methoxy-3-(3-morpholinopropoxy)benzonitrile |
|
C15H20N2O3 |
详情 | 详情
|
(VI) |
66434 |
4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile |
675126-26-8 |
C15H19N3O5 |
详情 | 详情
|
(VII) |
66445 |
7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(1H)-one |
|
C16H21N3O4 |
详情 | 详情
|
(VIII) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(IV)
【1】
Knesl P.Roeseling D,Jordis U 2006. Improved synthesis of substituted 6,7-rdihydroxy-4iuinazolinearninest: tandutinib, erlotinib and gefitinib. Molecules, 11(4):286~297 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
65853 |
5-Hydroxy-7-methoxy-3,4-dihydroquinazolin-4-one; 5-Hydroxy-7-methoxy-3H-quinazolin-4-one |
|
C9H8N2O3 |
详情 | 详情
|
(II) |
66446 |
7-methoxy-4-oxo-1,4-dihydroquinazolin-6-yl acetate |
|
C11H10N2O4 |
详情 | 详情
|
(III) |
18687 |
4-chloro-7-methoxy-6-quinazolinyl acetate
|
230955-75-6 |
C11H9ClN2O3 |
详情 | 详情
|
(IV) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
(V) |
66447 |
4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl acetate hydrochloride;6-Acetoxy-4-(3-chloro-4-fluoroanilino)-7-methoxyquinazoline hydrochloride |
184475-70-5 |
C17H13ClFN3O3.HCl |
详情 | 详情
|
(VI) |
18690 |
4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinol
|
184475-71-6 |
C15H11ClFN3O2 |
详情 | 详情
|
(VII) |
18691 |
4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine |
7357-67-7 |
C7H14ClNO |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(IX)
【1】
Wang JQ, Gao MZ, Miller KD, et al.2006. Synthesis of (11 C) iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase. Bioorg Med Chem Lett, 16 (15): 4102~4106 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
54574 |
3-hydroxy-4-methoxybenzonitrile
|
52805-46-6 |
C8H7NO2 |
详情 | 详情
|
(II) |
18691 |
4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine |
7357-67-7 |
C7H14ClNO |
详情 | 详情
|
(III) |
66433 |
4-methoxy-3-(3-morpholinopropoxy)benzonitrile |
|
C15H20N2O3 |
详情 | 详情
|
(IV) |
66434 |
4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile |
675126-26-8 |
C15H19N3O5 |
详情 | 详情
|
(V) |
66435 |
2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile |
675126-27-9 |
C15H21N3O3 |
详情 | 详情
|
(VI) |
66441 |
2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide |
|
C15H23N3O4 |
详情 | 详情
|
(VII) |
66445 |
7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(1H)-one |
|
C16H21N3O4 |
详情 | 详情
|
(VIII) |
66443 |
4-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine |
|
C16H20ClN3O3 |
详情 | 详情
|
(IX) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
(X) |
66448 |
4-((3-chloro-4-fluorophenyl)amino)-6-(3-morpholinopropoxy)quinazolin-7-ol |
847949-49-9 |
C21H22ClFN4O3 |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(XIX) The 7-methoxy-6-nitroquinazoline derivative (I) can be prepared by cyclization of 2-amino-4-fluorobenzoic acid (XIV) with formamidine acetate (XV) in 2-methoxyethanol to yield 7-fluoroquinazolin-4(3H)-one (XVI), which is then nitrated with HNO3 and H2SO4 to give 7-fluoro-6-nitroquinazolin-4(3H)-one (XVII) (1). Chlorination of quinazolinone (XVII) with SOCl2 at reflux provides 4-chloro-7-fluoro-6-nitroquinazoline (XVIII) , which is then coupled with 3-chloro-4-fluoroaniline (XIX) by means of Et3N or PhNMe2 in i-PrOH to produce the diarylamine (XX). Finally, fluoroquinazoline (XX) is treated with MeOH and NaH in .
【1】
Fakhoury, S.A., Lee, H.T., Reed, J.E., Schlosser, K.M., Sexton, K.E., Tecle, H., Winters, R.T. (Pfizer, Inc.). 4-Phenylamino-quinazolin-6-yl-amides. EP 1746999, JP 200753668, JP 2009007363, US 2005250761, US 7772243, WO 2005107758. |
【3】
Bridges, A.J., Klohs, W.D., Driscoll, D. (Pfizer, Inc.). N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases. EP 1131304, JP 2002530386, US 6344455, WO 2000031048. |
【4】
Smaill, J.B., Rewcastle, G.W., Loo, J.A. et al. Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(Phenylamino) quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solublizing functions. J Med Chem 2000, 43(7): 1380-97. |
【2】
Bridges, A.J., Horne, N.M., Jacks, T.E. et al. (Pfizer, Inc.). Preparation of substituted quinazolines. JP 2006517959, US 2004158065, WO 2004069791. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
68469 |
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine |
|
C15H10ClFN4O3 |
详情 | 详情
|
(XIV) |
10805 |
2-Amino-4-fluorobenzoic acid
|
446-32-2 |
C7H6FNO2 |
详情 | 详情
|
(XV) |
67709 |
formamidine acetate |
3473-63-0 |
CH4N2.C2H4O2 |
详情 | 详情
|
(XVI) |
19140 |
7-fluoro-4(3H)-quinazolinone
|
|
C8H5FN2O |
详情 |
详情
|
(XVII) |
19141 |
7-fluoro-6-nitro-4(3H)-quinazolinone
|
|
C8H4FN3O3 |
详情 |
详情
|
(XVIII) |
19142 |
4-chloro-7-fluoro-6-nitroquinazoline
|
|
C8H3ClFN3O2 |
详情 |
详情
|
(XIX) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
(XX) |
54956 |
N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine; N-(3-chloro-4-fluorophenyl)-N-(7-fluoro-6-nitro-4-quinazolinyl)amine
|
162012-67-1 |
C14H7ClF2N4O2 |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(XIX) Compound (XIII) can be obtained by reductocondensation of 3-chloro-4-fluoroaniline (XIX) with 3,4-dimethoxybenzaldehyde (XXI) using NaCNBH3 or NaBH(OAc)3 in AcOH/i-PrOH to yield the benzylaniline derivative (XXII), which by condensation with 4-chloro-7-fluoro-6-nitroquinazoline (XVIII) in i-PrOH gives the tertiary amine (XXIII) . Substitution of fluoroquinazoline (XXIII) with NaOMe in refluxing MeOH affords the 7-methoxyquinazoline derivative (XXIV), which is reduced to the quinazoline-4,6-diamine (XXV) by means of H2 over Raney Ni in THF. Finally, compound (XXV) is coupled with 4-(piperidin-1-yl)-2-butenoyl chloride (IV) in DMA .
4-(Piperidin-1-yl)-2-butenoyl chloride (IV) can be prepared by condensation of methyl 4-bromocrotonate (XI) with piperidine (X) to yield methyl 4-(piperidin-1-yl)-2-butenoate (XXVI), which is then hydrolyzed with HCl to give 4-(piperidin-1-yl)-2-butenoic acid (XXVII). Finally, acid (XXVII) is reacted with (COCl)2 in the presence of DMF in CH2Cl2 .
【1】
Fakhoury, S.A., Lee, H.T., Reed, J.E., Schlosser, K.M., Sexton, K.E., Tecle, H., Winters, R.T. (Pfizer, Inc.). 4-Phenylamino-quinazolin-6-yl-amides. EP 1746999, JP 200753668, JP 2009007363, US 2005250761, US 7772243, WO 2005107758. |
【2】
Bridges, A.J., Horne, N.M., Jacks, T.E. et al. (Pfizer, Inc.). Preparation of substituted quinazolines. JP 2006517959, US 2004158065, WO 2004069791. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XXVI) |
68482 |
(E)-methyl 4-(piperidin-1-yl)but-2-enoate |
|
C10H17NO2 |
详情 | 详情
|
(IV) |
68473 |
4-(piperidin-1-yl)-2-butenoyl chloride;(E)-4-(piperidin-1-yl)but-2-enoyl chloride |
|
C9H14ClNO |
详情 | 详情
|
(X) |
10158 |
Piperidine
|
110-89-4 |
C5H11N |
详情 | 详情
|
(XI) |
26358 |
methyl (E)-4-bromo-2-butenoate
|
1117-71-1 |
C5H7BrO2 |
详情 | 详情
|
(XIII) |
68477 |
(E)-N-(4-((3-chloro-4-fluorophenyl)(3,4-dimethoxybenzyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide |
|
C33H35ClFN5O4 |
详情 | 详情
|
(XVIII) |
19142 |
4-chloro-7-fluoro-6-nitroquinazoline
|
|
C8H3ClFN3O2 |
详情 |
详情
|
(XIX) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
(XXI) |
18304 |
3,4-Dimethoxybenzaldehyde; Veratraldehyde
|
120-14-9 |
C9H10O3 |
详情 | 详情
|
(XXII) |
68478 |
3-chloro-N-(3,4-dimethoxybenzyl)-4-fluoroaniline |
|
C15NClFO2 |
详情 | 详情
|
(XXIII) |
68479 |
N-(3-chloro-4-fluorophenyl)-N-(3,4-dimethoxybenzyl)-6-fluoro-7-nitroquinazolin-4-amine |
|
C23H17ClF2N4O4 |
详情 | 详情
|
(XXIV) |
68480 |
N-(3-chloro-4-fluorophenyl)-N-(3,4-dimethoxybenzyl)-6-methoxy-7-nitroquinazolin-4-amine |
|
C24H20ClFN4O5 |
详情 | 详情
|
(XXV) |
68481 |
N4-(3-chloro-4-fluorophenyl)-N4-(3,4-dimethoxybenzyl)-6-methoxyquinazoline-4,7-diamine |
|
C24H22ClFN4O3 |
详情 | 详情
|
(XXVII) |
26709 |
(E)-4-(1-piperidinyl)-2-butenoic acid;(E)-4-(piperidin-1-yl)but-2-enoic acid |
|
C9H15NO2 |
详情 |
详情
|